Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Working Capital/Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 4.745.095.175.104.84

What is the latest Working Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Working Capital/Sales ratio of AUROBINDO PHARMA is 4.74 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20264.74
Mar20255.09
Mar20245.17
Mar20235.10
Mar20224.84

How is Working Capital/Sales of AUROBINDO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2026 4.74
-6.88
Mar2025 5.09
-1.55
Mar2024 5.17
1.37
Mar2023 5.1
5.37
Mar2022 4.84 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Working Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹98,468.2 Cr -0.3% 5.5% 53.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.3%

5.5%

53.8%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses